The Dawn Is Dawing, the Future Is Promising: Efficacy and Safety of pan-HER Inhibitors in Advanced Lung Adenocarcinoma With <i>HER2</i> Mutations

YANG Guang-jian; WANG Yan; KE E-e

doi:10.12019/j.issn.1671-5144.2022.04.003

YANG Guang-jian, WANG Yan, KE E-e. The Dawn Is Dawing, the Future Is Promising: Efficacy and Safety of pan-HER Inhibitors in Advanced Lung Adenocarcinoma With HER2 Mutations[J]. Journal of Evidence-Based Medicine, 2022, 22(4): 202-206. DOI: 10.12019/j.issn.1671-5144.2022.04.003

Citation:

YANG Guang-jian, WANG Yan, KE E-e. The Dawn Is Dawing, the Future Is Promising: Efficacy and Safety of pan-HER Inhibitors in Advanced Lung Adenocarcinoma With HER2 Mutations[J]. Journal of Evidence-Based Medicine, 2022, 22(4): 202-206. DOI: 10.12019/j.issn.1671-5144.2022.04.003

Citation:

YANG Guang-jian, WANG Yan, KE E-e. The Dawn Is Dawing, the Future Is Promising: Efficacy and Safety of pan-HER Inhibitors in Advanced Lung Adenocarcinoma With HER2 Mutations[J]. Journal of Evidence-Based Medicine, 2022, 22(4): 202-206. DOI: 10.12019/j.issn.1671-5144.2022.04.003

The Dawn Is Dawing, the Future Is Promising: Efficacy and Safety of pan-HER Inhibitors in Advanced Lung Adenocarcinoma With HER2 Mutations

Graphical Abstract

Abstract

FullText(HTML)

References (14)

The Dawn Is Dawing, the Future Is Promising: Efficacy and Safety of pan-HER Inhibitors in Advanced Lung Adenocarcinoma With HER2 Mutations

Catalog

Export File

Citation

Format

Content